Minami; S. Sakura

Patent Applications and Registrations

Patent applications and USPTO patent grants for Minami; S. Sakura.The latest application filed is for "blood plasma fractions as a treatment for aging-associated cognitive disorders".

Company Profile

12.8.16

Minami; S. Sakura - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products Grant 11,413,308 - Braithwaite , et al. August 16, 2	2022-08-16
Methods and compositions for treating aging-associated impairments using CCR3-inhibitors Grant 11,382,907 - Braithwaite , et al. July 12, 2	2022-07-12
Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive Disorders App 20220152161 - Bell; David ; et al.	2022-05-19
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products App 20210315932 - Braithwaite; Steven P. ; et al.	2021-10-14
Methods and Compositions for Treating Aging-Associated Impairments with Trefoil Factor Family Member 2 Modulators App 20210301013 - Czirr; Eva ; et al.	2021-09-30
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products Grant 11,040,068 - Braithwaite , et al. June 22, 2	2021-06-22
Methods and Compositions for Treating Aging-Associated Impairments with Trefoil Factor Family Member 2 Modulators App 20210171626 - Czirr; Eva ; et al.	2021-06-10
Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression App 20210113612 - Braithwaite; Steven P. ; et al.	2021-04-22
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products App 20210060063 - Braithwaite; Steven P. ; et al.	2021-03-04
Blood plasma and plasma fractions as therapy for tumor growth and progression Grant 10,905,717 - Braithwaite , et al. February 2, 2	2021-02-02
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products Grant 10,874,692 - Braithwaite , et al. December 29, 2	2020-12-29
Methods and Compositions for Treating Aging-Associated Impairments Using CCR3-Inhibitors App 20200054622 - Braithwaite; Steven P. ; et al.	2020-02-20
Blood plasma fractions as a treatment for aging-associated cognitive disorders Grant 10,525,107 - Bell , et al. J	2020-01-07
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products App 20190328782 - Braithwaite; Steven P. ; et al.	2019-10-31
Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive Disorders App 20190321449 - Bell; David ; et al.	2019-10-24
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products App 20190282617 - Braithwaite; Steven P. ; et al.	2019-09-19
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products Grant 10,357,513 - Braithwaite , et al. July 23, 2	2019-07-23
Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression App 20190167719 - Braithwaite; Steven P. ; et al.	2019-06-06
Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR-Inhibitors App 20190111042 - Braithwaite; Steven P. ; et al.	2019-04-18
Methods and Compositions for Treating Aging-Associated Impairments Using CCR3-Inhibitors App 20190105314 - Braithwaite; Steven P. ; et al.	2019-04-11
Blood plasma and plasma fractions as therapy for tumor growth and progression Grant 10,245,285 - Braithwaite , et al.	2019-04-02
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products App 20180311280 - Braithwaite; Steven P. ; et al.	2018-11-01
Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive Disorders App 20180110839 - Bell; David ; et al.	2018-04-26
Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression App 20170340671 - Braithwaite; Steven P. ; et al.	2017-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.